The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 15, 2017
Filed:
Sep. 13, 2013
Applicants:
Université DE Droit ET DE Santé DE Lille Ii, Lille, FR;
Université DE Tours Francois Rabelais, Tours, FR;
Centre Hospitalier Régional Universitaire DE Lille, Lille, FR;
Inventors:
Didier Betbeder, Houplin Ancoisne, FR;
Isabelle Dimier-Poisson, Tours, FR;
Céline Ducournau, Louans, FR;
Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/02 (2006.01); A61K 39/04 (2006.01); A61K 39/39 (2006.01); A61K 9/00 (2006.01); A61K 9/51 (2006.01); A61K 39/002 (2006.01); A61K 47/48 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 9/0043 (2013.01); A61K 9/5123 (2013.01); A61K 9/5161 (2013.01); A61K 39/00 (2013.01); A61K 39/002 (2013.01); A61K 47/48923 (2013.01); A61K 2039/543 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/57 (2013.01); A61K 2039/6018 (2013.01); A61K 2039/6087 (2013.01);
Abstract
A pharmaceutical composition for its use in the prophylactic treatment of a patient against an intracellular pathogen, said composition comprising a solid nanoparticle comprising a porous cationic-polysaccharide solid core, loaded with at least an anionic phospholipid, without said cationic-polysaccharide core being surrounded by any phospholipidic layer, and at least an antigen obtained from said pathogen.